Digital Breast Tomosynthesis Market By Product (DBT Equipment, & 3-D Upgradation), By End User (Hospitals, and Diagnostic Centres), and by Region-Forecast (2014-2021)

  • ID: 3919899
  • Report
  • 135 pages
  • IndustryARC
1 of 3
Digital breast tomosynthesis (DBT) is a 3D breast imaging technique that is built on full field digital mammography technology. DBT systems creates multiple projection images of the breasts which is obtained from various angles of the rotating X-Ray tube at a low radiation dose via the compressed breast. Images are reconstructed into multiple slices of 1mm thickness and viewed on a monitor approved for tomosynthesis. This will minimise the impact of tissue superimposition that will result in improved visualisation of the internal structures. Typically, breast screening was performed step by step, starting with full-field digital mammography (FFDM or 2D mammography) followed by digital breast tomosynthesis (3D mammography) or breast Magnetic Resonance Imaging (MRI). FFDM is considered as the gold standard in breast cancer screening. conversely, with the introduction of DBT technology, it is slowly being replaced. DBT is frequently used as an adjunct technique with FFDM. Research and studies are being undertaken to consider DBT as a primary screening tool, particularly in patients with dense breasts. 3D mammography has proven to be better than 2D mammography in multiple clinical trials, which has led to an increase in its adoption. Combination of 2D and 3D mammography has become the new standard of care since 3D mammography compliments conventional 2D mammography.

This report identifies the global digital breast tomosynthesis market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to digital breast tomosynthesis market.

Geographically North America dominated global digital breast tomosynthesis market, and is projected to have fastest growth, owing to early adoption of this technology in this region.

This report segments global Digital Breast Tomosynthesis market on the basis of product, by end user, and by Region are as follows:

Digital Breast Tomosynthesis Market, by Product: DBT Equipment, & 3-D Upgradation
Digital Breast Tomosynthesis Market, by End-User: Hospitals, and Diagnostic Centres
This is report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region.

This report identifies all the major companies operating in the Digital Breast Tomosynthesis market. Some of the major companies’ profiles in detail are as follows:

Hologic Inc.
Siemens Healthineers
Fujifilm Corporation
GE Healthcare
Internazionale Medico Scientifica S.r.l.
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
Note: Product cover images may vary from those shown
2 of 3
1. Digital Breast Tomosynthesis Market Overview
2. Executive Summary
3. Digital Breast Tomosynthesis Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.3. Product Benchmarking
3.4. End User Profiling
3.5. Top 5 Financials Analysis
4. Digital Breast Tomosynthesis Market Forces
4.1. Drivers
4.1.1. Risk of developing cancer is directly proportional to age
4.1.2. Increasing life expectancy in developing countries
4.2. Restraints
4.2.1. High cost of the device
4.3. Opportunities
4.3.1. BRIC nation
4.4. Challenges
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition
5. Digital Breast Tomosynthesis Market - By Product
5.1. DBT Equipment
5.2. 3-D Upgradation
6. Digital Breast Tomosynthesis Market - By End-User
6.1. Hospitals
6.2. Diagnostic Centres
7. Global Digital Breast Tomosynthesis Market - By Geography (2014-2021)
7.1. Europe
7.1.1. Germany
7.1.2. France
7.1.3. Italy
7.1.4. Spain
7.1.5. Russia
7.1.6. U.K.
7.1.7. Rest of Europe
7.2. Asia Pacific
7.2.1. China
7.2.2. India
7.2.3. Japan
7.2.4. South Korea
7.2.5. Rest of Asia-Pacific
7.3. North America
7.3.1. U.S.
7.3.2. Canada
7.3.3. Mexico
7.4. Rest of the World (RoW)
7.4.1. Brazil
7.4.2. Rest of RoW
8. Digital Breast Tomosynthesis - Market Entropy
8.1. Expansion
8.2. Technological Developments
8.3. Merger & Acquisitions, and Joint Ventures
8.4. Supply - Contract
9. Company Profiles (Top 10 Companies)
9.1. Hologic Inc.
9.1.1. Introduction
9.1.2. Financials
9.1.3. Key Insights
9.1.4. Key Strategy
9.1.5. Product Portfolio
9.1.6. SWOT Analysis
9.2. Siemens Healthineers
9.2.1. Introduction
9.2.2. Financials
9.2.3. Key Insights
9.2.4. Key Strategy
9.2.5. Product Portfolio
9.2.6. SWOT Analysis
9.3. Fujifilm Corporation
9.3.1. Introduction
9.3.2. Financials
9.3.3. Key Insights
9.3.4. Key Strategy
9.3.5. Product Portfolio
9.3.6. SWOT Analysis
9.4. GE Healthcare
9.4.1. Introduction
9.4.2. Financials
9.4.3. Key Insights
9.4.4. Key Strategy
9.4.5. Product Portfolio
9.4.6. SWOT Analysis
9.5. Internazionale Medico Scientifica S.r.l.
9.5.1. Introduction
9.5.2. Financials
9.5.3. Key Insights
9.5.4. Key Strategy
9.5.5. Product Portfolio
9.5.6. SWOT Analysis
9.6. Dexela Ltd.
9.6.1. Introduction
9.6.2. Financials
9.6.3. Key Insights
9.6.4. Key Strategy
9.6.5. Product Portfolio
9.6.6. SWOT Analysis
9.7. IMS S.r.l.
9.7.1. Introduction
9.7.2. Financials
9.7.3. Key Insights
9.7.4. Key Strategy
9.7.5. Product Portfolio
9.7.6. SWOT Analysis
9.8. Analogic Corporation
9.8.1. Introduction
9.8.2. Financials
9.8.3. Key Insights
9.8.4. Key Strategy
9.8.5. Product Portfolio
9.8.6. SWOT Analysis
9.9. Sonociné, Inc.
9.9.1. Introduction
9.9.2. Financials
9.9.3. Key Insights
9.9.4. Key Strategy
9.9.5. Product Portfolio
9.9.6. SWOT Analysis
9.10. Aurora Imaging Technology, Inc.
9.10.1. Introduction
9.10.2. Financials
9.10.3. Key Insights
9.10.4. Key Strategy
9.10.5. Product Portfolio
9.10.6. SWOT Analysis

"*Financials would be provided on a best efforts basis for private companies"
10. Appendix
10.1. Abbreviations
10.2. Sources
10.3. Research Methodology
10.4. Expert Insights
Note: Product cover images may vary from those shown
3 of 3


4 of 3
Note: Product cover images may vary from those shown